QualityStocksNewsBreaks – Diagnos Inc. (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) Provides Regulatory Update on CARA AI Platform
This article has been disseminated on behalf of Diagnos Inc. and may include paid advertising. Diagnos (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) provided an update on the regulatory pathway for its CARA artificial intelligence platform for early detection of eye-related health issues, following its previously announced acceleration plan. The Corporation confirmed progress across three targeted jurisdictions, including formal submission to the Saudi Food and Drug Authority for marketing approval, ongoing engagement with Health Canada with a formal application expected this quarter, and clarification of 510(k) requirements with the U.S. Food & Drug Administration, positioning CARA for potential commercialization in…
